BDBM393276 5-(3,4- difluorobenzenesulfon- amidomethyl)-6- methyl-N-[(2-methyl- 1,3-thiazol-5- yl)methyl]pyrazine-2- carboxamide::US9963434, Table 12.219

SMILES Cc1ncc(CNC(=O)c2cnc(CNS(=O)(=O)c3ccc(F)c(F)c3)c(C)n2)s1

InChI Key InChIKey=GZXSPNTWOSSNMG-UHFFFAOYSA-N

Data  1 IC50

PDB links: 1 PDB ID matches this monomer.

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 393276   

TargetGlutamate receptor ionotropic, NMDA 2A(Homo sapiens (Human))
Luc Therapeutics

US Patent
LigandPNGBDBM393276(5-(3,4- difluorobenzenesulfon- amidomethyl)-6- met...)
Affinity DataIC50:  16.2nMAssay Description:Cell Culture and plating: HEK293 cells expressing NR1/NR2A (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB